Identification of targets for rational pharmacological therapy in childhood craniopharyngiomaJacob M. Gump, Todd C. Hankinson|Acta Neuropathologica Communications|2015Cited by 127
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngiomaShannon Coy, Sandro Santagata, Andrew M. Donson et al.|Neuro-Oncology|2018Cited by 113
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysisEric Prince, Todd C. Hankinson|Neuro-Oncology|2024Cited by 50
CRAN-11. MULTIPLEXED IMMUNOFLUORESCENCE REVEALS POTENTIAL PD-1/PD-L1 PATHWAY VULNERABILITIES IN CRANIOPHARYNGIOMAShannon Coy, Sandro Santagata, Rumana Rashid et al.|Neuro-Oncology|2018Cited by 2